Healthcare Capital, the investment arm of the Kauvery Hospital Group, has invested an undisclosed amount of funding in Lifesigns, an intelligent patient monitoring solutions start-up. Kauvery Hospitals said it has been an early adopter and clinical partner in the start-up’s journey.
The investment will be used to primarily advance Lifesigns’ AI and predictive algorithm capabilities, further enhancing its proprietary patient monitoring platform. Lifesigns offers USFDA-approved hardware, software, dashboard, and AI integration, delivering proactive alerts and predictive insights across the patient journey—from ambulances to hospitals and home care.
- Also read: Lupin to transfer OTC consumer healthcare business to wholly owned subsidiary for ₹550-650 crore
“As a healthcare provider, we understand the critical need for advanced monitoring solutions that enhance patient safety and ease the burden on healthcare professionals,” Dr Aravindan Selvaraj, Executive Director, Kauvery Hospital and Healthcare Capital, said. “Lifesigns’ technology is a game-changer, and we are excited to support their mission in redefining patient monitoring with AI-powered predictive analytics,” he added.
“This investment from Healthcare Capital is a testament to the trust they place in our technology and its impact on healthcare outcomes,” said Hari Subramaniam, Founder and CEO of Lifesigns. “With this funding, we aim to push the boundaries of AI-driven patient monitoring, empowering healthcare professionals with predictive tools that eliminate uncertainty and enable confident decision-making.”
Launched in 2020, Lifesigns says it is also gearing up for its next funding round in the next couple of months where it plans to unveil new tech product and market expansion initiatives.
- Also read: Semiconductor equipment manufacturing firm Lam Research to invest ₹10,000 crore in Karnataka